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Abstract
Background Sirtuin 1 (SIRT1) is a NAD+ sensitive deacetylase that has been linked to longevity and has been suggested to
confer beneﬁcial effects that counter aging-associated deterioration. Muscle repair is dependent upon satellite cell function,
which is reported to be reduced with aging; however, it is not known if this is linked to an aging-suppression of SIRT1. This
study tested the hypothesis that Sirtuin 1 (SIRT1) overexpression would increase the extent of muscle repair and muscle function in older mice.
Methods We examined satellite cell dependent repair in tibialis anterior, gastrocnemius, and soleus muscles of 13 young
wild-type mice (20–30 weeks) and 49 older (80+ weeks) mice that were controls (n = 13), overexpressed SIRT1 in skeletal muscle (n = 14), and had a skeletal muscle SIRT1 knockout (n = 12) or a satellite cell SIRT1 knockout (n = 10). Acute muscle injury
was induced by injection of cardiotoxin (CTX), and phosphate-buffered saline was used as a vector control. Plantarﬂexor muscle force and fatigue were evaluated before or 21 days after CTX injection. Satellite cell proliferation and mitochondrial function were also evaluated in undamaged muscles.
Results Maximal muscle force was signiﬁcantly lower in control muscles of older satellite cell knockout SIRT1 mice compared
to young adult wild-type (YWT) mice (P < 0.001). Mean contraction force at 40 Hz stimulation was signiﬁcantly greater after
recovery from CTX injury in older mice that overexpressed muscle SIRT1 than age-matched SIRT1 knockout mice (P < 0.05).
SIRT1 muscle knockout models (P < 0.05) had greater levels of p53 (P < 0.05 MKO, P < 0.001 OE) in CTX-damaged tissues
as compared to YWT CTX mice. SIRT1 overexpression with co-expression of p53 was associated with increased fatigue resistance and increased force potentiation during repeated contractions as compared to wild-type or SIRT1 knockout models
(P < 0.001). Muscle structure and mitochondrial function were not different between the groups, but proliferation of satellite
cells was signiﬁcantly greater in older mice with SIRT1 muscle knockout (P < 0.05), but not older SIRT1 satellite cell knockout
models, in vitro, although this effect was attenuated in vivo after 21 days of recovery.
Conclusions The data suggest skeletal muscle structure, function, and recovery after CTX-induced injury are not signiﬁcantly
inﬂuenced by gain or loss of SIRT1 abundance alone in skeletal muscle; however, muscle function is impaired by ablation of
SIRT1 in satellite cells. SIRT1 appears to interact with p53 to improve muscle fatigue resistance after repair from muscle injury.
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Introduction
Sarcopenia is the age-associated wasting of skeletal muscle
which results in a loss of function.1 Sarcopenia is accompanied by an increased risk for physical disabilities, fall-induced
injuries, hospitalization/institutionalization, and mortality,2
and it is exacerbated by obesity and metabolic disorders.3 Mitochondria regulate muscle metabolism and mitochondrial
dysfunction may play a role in sarcopenia.4 Indeed, altered
size and granularity have been observed in aging mitochondria, 5,6 as well as in the mitochondria of subjects diagnosed
with type 2 diabetes mellitus.7 Concordantly, loss of mitochondrial function also occurs with aging and metabolic disorders,8 although some research suggests age-associated
alterations in mitochondrial morphology are independent of
lifespan.9 It is interesting that the highly oxidative type I muscle ﬁbres, which have ~6% mitochondria volume,10 are generally thought to be more resistant to sarcopenia-related
muscle wasting than type II ﬁbres11 which have ~3% mitochondria volume density.10 This might be due in part to a
greater sensitivity of mitochondria in type II ﬁbres to oxidative stress.12 Preserving mitochondrial function is therefore
a potential strategy for reducing sarcopenia in both ﬁbre
types.
Sirtuin 1 (SIRT1) is a class III histone deacetylase13 which is
dependent on NADH to deacetylate its targets, making SIRT1
highly sensitive to changes in metabolism. SIRT1 has been
identiﬁed as a link between caloric restriction and longevity,
with the overexpression of SIRT1 linked to increased lifespans
for several organism models.14 Furthermore, SIRT1 has also
been shown to inhibit type I ﬁbre atrophy during intermittent
fasting, by deacetylating and inhibiting the transcription activity of FoxO1 and FoxO3.15 In addition, activating SIRT1 in
muscle cells prevents the reduction in slower ﬁbre type myosin heavy chain (MHC) gene expression and prevents
myotube wasting after glucose.16,17 Importantly, SIRT1 has
been identiﬁed as a regulator of protein peroxisome
proliferator activated receptor gamma coactivator 1α
(PGC1α),18 which is a well-established regulator of mitochondrial biogenesis and glycolytic-to-oxidative ﬁbre type
switching in mammalian skeletal muscle.19 PGC-1α activation
(i.e. deacetylation) occurs via AMPK activation of the
deacetylase SIRT1.20 In fact, SIRT1 deacetylation of PGC-1α
increases the expression of key glucose and lipid metabolism
genes.21 However, mitochondrial biogenesis in response to
exercise is not impaired under SIRT1 knock out conditions,
and therefore, SIRT1 deacetylation is thought to be via the
control of acetyltransferase GCN5.22
Satellite cell dysfunction is another potential contributor to
muscle loss in sarcopenia.23 Satellite cells are mononucleated
muscle stem cells that are responsible for the majority of
muscle regeneration after injury.24,25 Both the expression of
SIRT1 and satellite cell populations have been shown to decrease with aging,26 inviting the possibility that increasing
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SIRT1 expression in older muscle models might act as a countermeasure to preserve muscle regenerative capacity and
therefore improve muscle function after muscle injury in aging. Consistent with this idea, resistance exercise coupled
with consuming resveratrol, a known activator of SIRT1, increased satellite cell proliferation and improved muscle ﬁbre
size and function in muscles of older humans to a greater extent than resistance exercise alone.27 Furthermore, resveratrol also prevents cell death and increases differentiation of
myotubes,28 whereas SIRT1 silencing evokes greater cell
death and reduced differentiation.28 In addition, SIRT1 was
reported to maintain pools of satellite cells in the state of quiescence, and SIRT1 loss of function was reported to invoke
premature differentiation of muscle satellite cells.29 Strengthening this argument, mild endurance exercise which increased SIRT1 was shown to rescue an aging-induced
reduction in satellite cell numbers in rats.26,30 However, other
studies have shown differential patterns of SIRT1 expression
according to age and tissue type,31 calling into question
whether aging has universal effects on SIRT1. Thus, there is
a need to further study the role of SIRT1 on mitochondrial
function and satellite cell regulation of muscle repair in the
context of muscle sarcopenia.
The purpose of this study was to investigate the role of
SIRT1 in repairing muscle and restoring skeletal muscle function after acute muscle damage in older mice. Our hypothesis
was that muscle overexpression of SIRT1 improves mitochondrial function and satellite cell activation, which improves
muscle repair and function after acute injury, and in contrast,
loss of SIRT1 in muscle or satellite cells of older mice reduces
muscle repair and function after injury by suppressing satellite cell activation and reducing mitochondrial function. Contrary to our expectation, we found that muscle
performance and the recovery of skeletal muscle after injury
are largely unaffected by the abundance of SIRT1 in skeletal
muscle, but ablation of SIRT1 in satellite cells impairs muscle
repair and function. Nevertheless, SIRT1 abundance may
work synergistically with p53 to reduce muscle fatigue after
repair following muscle injury.

Materials and methods
Research design
Two separate experiments were conducted on the ﬁve
groups of mice. Three to ﬁve mice were examined in each
age group for each experimental comparison. In the ﬁrst experiment, the plantarﬂexor muscles (gastrocnemius and soleus muscles) received an acute cardiotoxin (CXT)-induced
injury. Plantarﬂexor force and fatigue were measured before
and then again after 21 days of recovery following CTX injury
to assess the degree that manipulation of SIRT1 protein
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abundance had on muscle function and recovery/repair from
muscle damage. In a separate study, the plantarﬂexor muscles and the dorsiﬂexor [tibialis anterior (TA)] muscles from
mice in each of the ﬁve groups received a CTX injection to induce acute muscle injury. These muscles were used to assess
the role of SIRT1 on muscle structure solely. As there was the
potential that electrical stimulation to induce evoked contractions could affect muscle ﬁbre size or structure acutely, we
did not assess muscle function in this second study.

Animal models
Five mouse models were examined. These included (i) young
wild-type (YWT) mice that were 20–30 weeks of age, (ii) older
wild-type mice that were 80–120 weeks of age (WT-80), (iii)
SIRT1 overexpressor older mice that were 80–120 weeks of
age (OE-80), (iv) SIRT1 older adult skeletal-muscle knockout
mice that were 80–120 weeks of age (MKO-80), and (v) SIRT1
satellite cell knockout mice that were 80–120 weeks of age
(SKO-80). As ~50% of the animals died before they were
120 weeks of age, we chose to include older animals that
were 80 weeks of age in our oldest group because this is at
a point where muscle signalling changes and muscle atrophy
and function begins to deteriorate.32,33 While these animals
could not yet be considered to be old, this group had mice that
ranged in age from 80–120 weeks, and the oldest animals in
this group would be considered old. Therefore, we have chosen
to describe this combined group as ‘older’. All wild-type mice
were generated from C57BL/6J background mice purchased
from Jackson Laboratories, USA. MKO-80 and SKO-80
mice were generated using the cre-lox system by crossing
B6;129-Sirt1tm1Ygu/J mice containing loxP sites directing the
removal of exon 4 of SIRT1 with MCK-cre expressing B6.
FVB(129S4)-Tg (Ckmm-cre)5Khn/J and PAX7-cre expressing
Pax7tm1(cre)Mrc/J mice, respectively. Mice that overexpressed
SIRT1 were generated from B6.Cg-Tg (SIRT1)ASrn/J mice
containing a wild-type mouse SIRT1 gene promoted by an
endogenous bacterial artiﬁcial chromosome (BAC) transgene.

Cardiotoxin-induced acute muscle injury
Acute muscle injury was induced by injecting the
gastrocnemius, soleus, and TA muscles with 10 μM CTX (Naja
mosambica; Sigma, St. Louis MO, USA)34 in 150 μL of
phosphate-buffered saline (PBS). The contralateral limb was
injected with 150 μL of PBS as a vehicle control. Cage control
recovery occurred for 21 days post-injection. During
recovery, mice were given water containing 0.8 mg/mL of
5-bromo-20 -deoxyuridine (BrdU) (MP Biomedicals) to identify
satellite cells that achieved DNA synthesis over the recovery
period as previously used in our lab.24 Post-recovery, the
experimental groups were euthanized by myocardial extraction

under heavy anaesthesia. The muscles were then immediately
collected and frozen in 2-methylbutane (ThermoFisher
Scientiﬁc, Pittsburgh PA, USA) chilled by liquid nitrogen. Frozen
tissue sections were mounted on corkboard with Tissue Tek
O.C.T. compound (ThermoFisher Scientiﬁc, Pittsburgh PA, USA).

BrdU immunohistochemistry
Frozen tissue sections of control and post-CTX injured
muscles were obtained with a Leica model CM3050S cryostat,
and the tissue was mounted on charged glass slides
(ThermoFisher Scientiﬁc, Pittsburgh PA, USA). The frequency
of muscle nuclei that were BrdU positive were measured as
previously described by our lab.24 Brieﬂy, the slides were
ﬁxed at room temperature with 1:1 methanol:acetone
(ThermoFisher Scientiﬁc, Pittsburgh PA, USA) and then
permeabilized with PBS in 0.4% Triton X-100. Slides were
then washed with PBS and allowed to incubate in 2 M hydrochloric acid (ThermoFisher Scientiﬁc, Pittsburgh PA, USA) for
1 h at room temperature, followed by neutralization in
0.1 M Borate Buffer (pH 8.5). The tissue sections were
blocked with 10% normal goat serum (Vector Laboratories,
Burlingame, CA, USA) and incubated overnight in primary
antibodies targeting BrdU (1:100, Developmental Studies
Hybridoma Bank, Iowa City, IA, USA). Secondary antibodies
targeting IgG1 (AlexaFluor-488, Invitrogen-ThermoFisher
Scientiﬁc, Carlsbad CA, USA) were used for ﬂuorescent
imaging of BrdU+ nuclei. Images were captured with a Nikon
E800 microscope. BrdU+ cells were quantiﬁed using ImageJ
software (National Institutes of Health, Bethesda, Maryland).
BrdU+ labelled nuclei were quantiﬁed if they could be clearly
associated with either the periphery or interior of a muscle
ﬁbre. All of the nuclei from six nonoverlapping ﬁelds were
quantiﬁed with light microscopy at an objective magniﬁcation
of 40×. There were two repeats for each biological section
and the data averaged for each section. The BrdU labelling
index was expressed as a percent of the total nuclei and
determined by: (the number of BrdU-positive nuclei
associated with muscle ﬁbres)/(labelled unlabelled nuclei
associated with muscle ﬁbres). Data are presented as
mean ± standard deviation.

Fibre-type immunohistochemistry
Muscle ﬁbre types were identiﬁed using antibodies to MHCs
as previously reported by Bloemberg and Quadrilatero,35
with slight modiﬁcations as reported by our lab.24 Brieﬂy,
isolated muscles were ﬂash frozen in 2-methylbutane chilled
by liquid nitrogen and mounted on corkboard with Tissue
Tek O.C.T. compound (ThermoFisher Scientiﬁc, Pittsburgh
PA, USA). Muscle tissue cross sections were obtained at
20°C with a Leica model CM3050S cryostat. Tissue sections
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were blocked with normal goat serum (Vector Labs, Burlingame, CA, USA) and stained with primary antibodies targeting
MHC I (BA-F8S), MHC IIa (SC-71), and MHC IIb (BF-F3), at a
1:100 dilution overnight at 4°C in a humidiﬁed chamber.
Primary antibodies were obtained from the Developmental
Studies Hybridoma Bank, Iowa City, IA USA. After washing
with PBS, the slides were incubated in secondary antibodies
at a 1:500 dilution for 2 h at room temperature. Secondary
antibodies targeting IgG2b (AlexaFluor-647), IgGM
(AlexaFluor-546), and IgG1 (AlexaFluor-488) were obtained
from Invitrogen-ThermoFisher Scientiﬁc, Carlsbad CA, USA,
and were used for ﬂuorescent imaging. Images were captured with a Nikon E800 microscope. Fibre cross-sectional
areas (CSA) were determined by planimetry from a minimum
of 500 ﬁbres taken from 8–12 randomly selected ﬁelds from
the tissue cross sections. All the ﬁbres encompassed in a ﬁeld
were traced. Mean ﬁbre area was calculated using ImageJ
software (National Institutes of Health, Bethesda, Maryland).
The cross-sectional images were captured with a Nikon E800
microscope. Whole muscle CSA was determined by tracing
the entire circumference of the muscle section if the section
could be captured as a single image, or otherwise as the summation of total muscle area traced from a composite picture.
Type I ﬁbre CSA was determined by individually tracing all
ﬂuorescently labelled ﬁbres within a given section, with
(n = 3) muscle sections per group.

Satellite cell isolation
To evaluate the role of SIRT1 on the potential for repair
during aging, mononuclear muscle cells were isolated from
the combined muscle mass of control non-CTX injured
mouse TA and quadriceps muscles from both hindlimbs
using the protocol of Pasut, and colleagues36 with some
modiﬁcations. Brieﬂy, muscle samples were cut into small
sections and incubated in 1500 U collagenase type II
(Worthington Biochemical, USA) in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) +10% horse serum, followed by
incubation in 300 U collagenase type II with 6 U dispase
(Gibco, Invitrogen, Gaithersburg, MD, USA) in DMEM +10%
horse serum. After trituration, muscle supernatants were
collected and ﬁltered through 40 μm cell strainers
(ThermoFisher Scientiﬁc, Pittsburgh PA, USA). Aliquots of
isolated mononuclear cells were then washed in PBS-azide
and blocked in 10% normal goat serum (Vector Labs,
Burlingame, CA, USA). Satellite cells were separated from
the muscle mononuclear cells by labelling the cells with
ﬂuorophore-conjugated primary antibodies as modiﬁed
from methods described by Liu et al.37 Brieﬂy, isolated
mononuclear cells were labelled with ﬂuorophore-conjugated
primary antibodies for the following cell surface markers:
CD31 (-APC), Sca-1 (-PacBlue), CD45 (-PE-Cy7), and VCAM-1
(-Biotin) (BioLegend, San Diego, CA, USA). A second incubation
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was used to bind Rhodamine-conjugated avidin (Vector Labs,
Burlingame, CA, USA) to the biotin-conjugated antibody.
After washing, the ﬂuorophore-conjugated cells were
resuspended in foetal bovine serum and VCAM+/CD31/
CD45/Sca-1 satellite cells were isolated by a FACSCalibur
ﬂow cytometer equipped with a 15-molecular weight (MW)
488 nm argon laser and 633 nm red diode laser (Becton
and Dickinson). All ﬂow cytometric measurements were
performed in conjunction with the West Virginia University
Flow Cytometry Core Facility.

Protein immunoprecipitation assays
Immunoprecipitation of selected proteins from cell lysates
was conducted as previously reported.38 Brieﬂy, muscle cells
were fractionated by the method described by Rothermel et
al.39 Protein isolates from skeletal muscles were incubated
for 1 h at 4°C with 25 μL of Pierce Protein A/G magnetic
beads (ThermoFisher Scientiﬁc, Pittsburgh PA, USA) to reduce
non-speciﬁc binding. Clean antigen solutions were then incubated for 2 h at 4°C with an anti-PGC1α primary antibody
(Santa Cruz Biotech. Sant Cruz, CA, USA). Pre-cleaned Protein
A/G beads were next added to the antigen/antibody mixture
and allowed to incubate overnight at 4°C. After the incubation, the Protein A/G beads were collected with a magnetic
apparatus and the supernatant was discarded. After washing,
the magnetic beads were again collected, and the precipitated proteins were eluted with a 1× NuPAGE LDS sample
buffer (ThermoFisher Scientiﬁc, Pittsburgh PA, USA) for
20 min at room temperature. Protein concentrations of samples were determined by the Lowry method, and the purity of
each fraction was conﬁrmed as reported previously.40 Forty
micrograms of protein were loaded into each well of a 4–12%
gradient polyacrylamide gel (Invitrogen, Carlsbad, CA) and
separated by routine sodium dodecyl sulfate-polyacrylamide
gel electrophoresis for 1 h at 120 V. The proteins were
transferred to a nitrocellulose membrane for 1.5 h at 25 V.
Non-speciﬁc protein binding was blocked by incubating the
membranes in 5% nonfat milk in Tris-buffered saline containing
0.05% Tween 20.24,41,42

Mitochondrial isolation
To evaluate the effect of SIRT1 on mitochondria, right and left
non-CTX injured hindlimb plantar ﬂexor muscles were collected from YWT and older SIRT1 variant-expression models,
with both hindlimb ﬂexor groups were pooled into a single
sample. Collected tissues were washed in PBS (pH 7.4).
Subsarcolemmal mitochondria (SSM) and interﬁbrillar mitochondria (IFM) were isolated as previously described.43,44 Mitochondrial pellets were resuspended in KME buffer (100 mM
Journal of Cachexia, Sarcopenia and Muscle 2019; 10: 929–949
DOI: 10.1002/jcsm.12437

933

The role of Sirt1 in muscle

KCl, 50 mM MOPS, and 0.5 mM EDTA; pH 7.4) for analysis of
mitochondrial enzymatic activity.45,46

Mitochondrial size, internal complexity, and
membrane potential
The size, internal complexity/granulation, and membrane potential of isolated mitochondria were analysed with a
FACSCalibur ﬂow cytometer equipped with a 15-MW
488 nm argon laser and 633 nm red diode laser (Becton
and Dickinson, Franklin Lakes, NJ, USA), as previously described.43,45 The ratiometric dye 5,50 ,6,60 -tetrachloro1,10 ,3,30 -tetraethylbenzimidazol carbocyanine iodide (JC-1;
Molecular Probes, Carlsbad, CA) was used to selectively
probe and gate for respiring mitochondria47 using 488 nm excitation with 530 and 590 nm bandpass emission ﬁlters. A
greater concentration of JC-1 aggregates form as a result of
greater mitochondrial uptake, which increases the orange
ﬂuorescent emission signal, as opposed to the green ﬂuorescent monomer of JC-1. The resultant ratio of orange ﬂuorescence (polarized mitochondrial membrane) to green
ﬂuorescence (depolarized mitochondrial membrane) was
used to characterize membrane potential for isolated mitochondrial subpopulations.
Size and internal complexity/granularity were determined
for mitochondrial populations with forward-scatter (absolute
particle size) and side-scatter (refracted light proportional to
mitochondrial granularity) detectors, respectively. All ﬂow cytometric measurements were performed in conjunction with
the West Virginia University Flow Cytometry Core Facility.

Mitochondrial electron transport chain complex
activities
The activities of mitochondrial complex I, III, and IV and ATP
synthase were determined as previously described.43 Complex I and ATP synthase activities were determined separately
by measuring the oxidation of NADH at 340 nm, while complex III and complex IV activities were determined separately
by measuring the reduction and oxidation of cytochrome c at
550 nm, respectively. Protein content was determined with
the Bradford method, and all complex activities were
expressed in nanomoles of oxygen consumed per minute
per milligram protein.

Muscle force and fatigue
Young wild-type (YWT) and older SIRT1 variant-expression
mouse models underwent measures to determine plantar
ﬂexor force and fatigability to assess the role of SIRT1 on
muscle recovery post-CTX injection. Functional measures

were obtained via indirect electric stimulation of the plantar
ﬂexor muscles through the tibial nerve and measured with
a custom-built dynamometer (Aurora Scientiﬁc, Aurora, Ontario, Canada) as previously described24,38 with the mice
anaesthetised under 2–3% isoﬂurane.
Electrically evoked contractions (200 μs pulse width) were
measured with the mice on a heated plate to maintain body
temperature under anaesthesia. Hindlimb ankles were positioned at 90° ﬂexion. The functional assessment began with
a three electrically evoked muscle twitches, followed by a
120 s rest. A second stimulation of 75 Hz was then applied
to induce tetanus followed by a 300 s rest. This was repeated
three times. Finally, a single series of 180 contractions were
performed at 40 Hz (330 ms of activation followed by
670 ms of rest) over a span of 180 s. All stimulations were applied to the common peroneal nerve with subcutaneous platinum electrons with 200 μs pulse width, via commercially
available stimulator and controlling software provided by Aurora Scientiﬁc (Aurora, Ontario, Canada). Mice were checked
continually for vitality and responsiveness. After the functional evaluation, the right hindlimb gastrocnemius and soleus muscles were each injected with 100 μL of 10 μM CTX
(Naja mosambica) to induce muscle damage34 as described
earlier. An equal volume of PBS was injected into the contralateral leg as a vector control. Muscle recovery/repair occurred for 21 days after CTX injection, and then, the plantar
ﬂexors were examined using the same physiological evaluation. Immediately following the functional measures, the
mice were euthanized by myocardial extraction under heavy
anaesthesia, and the hindlimb muscles were collected for
analysis.

Proliferation analysis
The proliferation potential of isolated populations of satellite
cells was quantiﬁed from CTX-injected and control TA muscles using Click-iT EdU Alexa Fluor 488 (InvitrogenThermoFisher Scientiﬁc, Carlsbad CA, USA). Brieﬂy, satellite
cells were isolated from TA muscles as described earlier.
The isolated cells were then resuspended in growth medium
DMEM (high glucose, L-glutamine) with 20% foetal bovine serum, 10% horse serum, and 1% antibiotic/antimycotic (Gibco,
Invitrogen, Gaithersburg, MD, USA) and plated overnight on
glass coverslips coated in 0.2% gelatin. Plated satellite cells
were then incubated for 1 h in 10 μM EdU in DMEM. After
incubation, the cells were ﬁxed in 1 mL of 3.7% formaldehyde
in PBS for 15 min at room temperature and then washed
twice with 1 mL of 3% bovine serum albumin in PBS. The cells
were then permeabilized in 1 mL of 0.5% Triton X-100 in PBS
for 20 min. After a second wash in PBS +3% bovine serum albumin, cells were treated with 500 μL of reaction buffer,
consisting of copper sulfate, the Alexa Fluor-conjugated
azide, and sodium ascorbate, and then allowed to incubate
Journal of Cachexia, Sarcopenia and Muscle 2019; 10: 929–949
DOI: 10.1002/jcsm.12437

934

for 30 min at room temperature, protected from light. The
cells then underwent a ﬁnal wash and were transferred to microscope slides for analysis with a Nikon E800 microscope.
Coefﬁcients of proliferation were calculated as the number
of illuminated cells counted on nine separate ﬁelds divided
by the number of cells plated. Experiments were run in triplicate and are presented as the mean ± standard deviation.
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antibodies to the same protein were used to conﬁrm staining
patterns and/or location of the protein band on a western
blot. Negative controls were conducted without the primary
antibody or without the secondary antibody to conﬁrm that
there was no inappropriate cross-labelling by the antibodies.

Statistical analysis
Western blot analysis
Skeletal muscle lysates were analysed with Western immunoblots as previously described,24,38,41,42 with slight modiﬁcations.
Sodium
dodecyl
sulfate-polyacrylamide
gel
electrophoresis was run on 4–12% gradient NuPAGE Bis-Tris
gels (ThermoFisher Scientiﬁc, Pittsburgh PA, USA) at 120 V
for 2 h in NuPAGE MES SDS buffer (ThermoFisher Scientiﬁc,
Pittsburgh PA, USA). Proteins were transferred to a nitrocellulose membrane for 1 h at 15 V with a Trans-Blot SD semi-dry
transfer cell (Bio-Rad). All proteins were probed at the same
time from the same samples, requiring only GAPDH loading
control. Membranes were then carefully cut to separate the
proteins based on protein MW to allow for the simultaneous
probing of multiple different proteins for each treatment
group. The MW for the proteins were: FoxO3a (80kDA), p53
(53kDA), and GAPDH (35.8kDA). After blocking with TBST
+5% nonfat dry milk, membranes were incubated overnight
at 4°C in 1:1000 dilutions of primary antibodies for SIRT1
(Millipore), PGC1α (Santa Cruz), GAPDH (Cell Signaling, Danvers, MA, USA), p53 (Cell Signaling, Danvers, MA, USA),
Acetyl-Lysine (Cell Signaling, Danvers, MA, USA), and FOXO3a
(Cell Signaling, Danvers, MA, USA). Membranes were then
incubated in linked anti-mouse and anti-rabbit secondary
antibodies at 1:5000 dilutions (Cell Signaling, Danvers,
MA, USA). Horseradish peroxidase (HRP) signals were
developed with an enhanced chemiluminescent substrate
(ThermoFisher Scientiﬁc, Pittsburgh PA, USA) with a G:Box
Bioimaging System (Syngene, Fredrick, MD, USA). Band
intensity was normalized to GAPDH.

Quantitative analysis was performed on experiments performed at least in triplicate. Statistically signiﬁcant differences between groups were determined using GraphPad
Prism 6 software (La Jolla, CA, USA) performing a two-way
analysis of variance (ANOVA) (age group × condition) with
corrections made for multiple comparisons against a baseline
control group by the Dunnett’s test. Fatigue analysis was performed using two-way repeated ANOVA with corrections for
multiple comparisons against the baseline control. Statistical
differences between right and left hindlimb pretreatment
groups for each genotype were compared using paired t-tests
for muscle force, indicating the difference between hindlimbs
was not signiﬁcant from zero. Multiple unpaired t-tests for
contractile force as a function of the number of muscle contractions was also performed between the left and right
hindlimb pretreatment groups for each genotype, also indicating no signiﬁcant difference between hindlimb function
within the individual models. As such, data for the left
hindlimb pretreatment groups were expressed as baseline
data for each model. Unpaired t-tests were also used, when
appropriate, to determine statistical signiﬁcance between
two groups, such as treatment and control groups within
each genotype, with signiﬁcant differences noted when present. Effect sizes were reported using the Cohen’s d statistic
and were calculated as the difference in means over the
pooled standard deviation. The results were expressed as
mean ± standard deviation (SD) (P < 0.05).

Results

Veriﬁcation of antibody speciﬁcity

Animal model characteristics

The antibodies which were used in our experiments were validated prior to utilization. We obtained antibodies that were
supplied from vendors which were able to provide validation,
maintenance testing, and production validation to ensure
that lots of the antibodies remained constant over the study
duration. In addition, validation of the antibodies included
testing on appropriate positive protein controls or mouse
models (deﬁcient in gene/protein) by immunoblot and immunostaining. Western blots were conducted to validate band
sizes, and immunohistochemistry on each antibody to check
for non-speciﬁc staining in tissue sections. Several different

Mouse models were categorized into ﬁve groups, based on
age and SIRT1 expression. Young wild-type (YWT) mice were
20–30 weeks of age, while older mice were 80–120 weeks
of age. The older mice included wild-type mice (WT-80),
SIRT1 overexpressor mice (OE-80), SIRT1 adult skeletal-muscle knockout mice (MKO-80), and SIRT1 satellite cell knockout
mice (SKO-80). Each group included both male and female
mice. Although the older mouse groups showed no signiﬁcant
differences in body weight between males and females, YWT
females were signiﬁcantly smaller than corresponding YWT
males (P ≤ 0.05) (Table 1).
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Table 1 Characteristics of study animals

Age (weeks)
Mass (g)—total
Mass (g)—males
Mass (g)—female
Male (%)
Female (%)
n

YWT

OWT

OE

MKO

SKO

24.8 ± 0.7
28.4 ± 1.4
32.1 ± 1.1*
24.0 ± 0.9*
53.9
46.2
13

83.7 ± 0.5
35.8 ± 2.1
37.3 ± 2.6
33.5 ± 3.6
61.6
38.5
13

86.9 ± 1.5
31.7 ± 0.8
32.7 ± 0.7
29.6 ± 1.7
66.7
33.3
14

90.1 ± 2.9
34.9 ± 1.5
34.9 ± 2.0
34.8 ± 2.5
58.3
41.7
12

84.2 ± 4.2
31.2 ± 1.7
34.5 ± 2.1
31.4 ± 2.1
30
70
10

Mass of each group was recorded immediately prior to euthanasia. Experimental groups consisted of randomly distributed males and females. Young wild-type (YWT) males differed signiﬁcantly in body mass only from YWT females (*P < 0.05). Data are expressed as
means ± SD.

SIRT1 protein abundance in the mouse models
To characterize differences in SIRT1 protein abundance between animal groups, the hindlimb muscles were collected
from young wild-type (YWT, n = 3) and older (80+ weeks)
wild-type (WT-80, n = 3), SIRT1 overexpressor (OE-80,
n = 3), SIRT1 skeletal muscle knockout (MKO-80, n = 3), and
SIRT1 satellite cell knockout (SKO-80, n = 3) mice, 21 days after PBS or CTX injection. The mice were examined prior to
and 2 h after exercise (-ex) because exercise is a known inducer of SIRT1.48 As expected, SIRT1 was greater in the OE
muscles and lowest in the muscles from SKO and MKO mice
(Figure 1B). These data indicate that SIRT1 protein levels
were as anticipated based on the crosses of the respective
animal models. SIRT1 was not absent in SKO-80 mice muscles,
although the SIRT1 protein abundance was signiﬁcantly lower
in PBS-injected, but not CTX-injected hindlimb muscles from
SKO-80 relative to YWT mice. Interestingly, ANOVA analyses
showed signiﬁcant differences between the OE-80 PBS and
SKO-80 PBS groups as compared to wild-type controls, but
not the MKO-80 PBS groups. However, the OE-80, SKO-80,
and MKO-80 muscle SIRT1 abundances were signiﬁcantly different from the wild-type controls when compared with individual t-tests (P < 0.05, data not shown). Only the muscles
from SKO-80 mice showed a signiﬁcant increase in SIRT1
abundance in CTX-injected muscles relative to their own
PBS group (P < 0.05).
We next measured FoxO3a and p53 protein abundance because they are downstream targets of SIRT1 (Figure 1C). Protein abundance was not markedly different for FoxO3a
among the groups. Abundance of p53 followed a similar distribution to the SIRT1 protein expression, although a signiﬁcant difference in p53 protein abundance was not detected
between the OE-80 groups and the YWT PBS control (Figure 1D). Interestingly, while a signiﬁcant increase in p53 protein abundance was not detected between injury-recovered
muscles and muscles treated with the saline control for either
the OE-80 or MKO-80 groups, the relative abundance of p53
for those groups was signiﬁcantly greater than the p53 abundance detected in muscles from the YWT CTX-injected mice
(comparison denoted by #). Even though the muscle protein

abundance of p53 in the YWT CTX mice differed signiﬁcantly
from the protein abundance levels in muscles from the OE80 CTX and the MKO-80 CTX groups, p53 protein abundance
in muscles from YWT CTX-injected mice did not differ signiﬁcantly from the levels found in muscles from the WT-80 CTX
and the SKO-80 CTX groups (Figure 2C–2H).
We also evaluated the acetylation status of PGC1α, another downstream target of SIRT1 to assess SIRT1 activity
(Figure 1E). Although we expected to see decreased acetylation of PGC1α in muscles from the SIRT1 overexpressor
mouse model and increased acetylation in the muscles from
SIRT1 knockout mice, qualitative analysis of immunoblots
showed no apparent change in acetylation state, regardless
of apparent PGC1α expression in the various mouse genotypes (Figure 1F).

Skeletal muscle function
Muscle force
We tested whether SIRT1 protein abundance had a role in
regulating skeletal muscle function in muscles of older mice
after acute injury induced by CTX. Before treatment, average,
evoked maximal plantar ﬂexion contractile force at 75 Hz
stimulation was signiﬁcantly lower in the older SKO-80 mice
as compared to YWT PRE, indicating a lower basal contraction
force in older mice deﬁcit of SIRT1 in satellite cell (Figure 2A).
Next, contractile force was assessed in each group following a
21-day recovery from acute injury by CTX or treatment with
PBS to determine if SIRT1 abundance in skeletal muscle had
an effect on the recovery of contractile function. Mean maximal contractile force in YWT mice generated at a stimulation
frequency of 75 Hz had recovered to control levels by 21 days
after CTX treatment. The maximal contractile force was significantly lower in the PBS-injected, vector control hindlimb for
WT-80 compared to the WT-80 PRE baseline, suggesting that
the older muscles in the WT-80 animals may have been susceptible to injection injury (Figure 2A). As expected, aging
per se resulted in a lower plantar ﬂexion maximal force production in wild-type mice, as seen by the lower force
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Figure 1 Protein expression in young wild-type and older variant SIRT1 expressing mice. (A) SIRT1 protein expression collected from 12-week-old wildtype (WT), overexpressor (OE), satellite cell knockout (SKO), and skeletal muscle knockout (MKO) mice prior to and 2 h after exercise (-ex). (B) Densitometric and immunoblot analysis of SIRT1 protein expression measured in young wild-type (YWT, n = 3) and older (80+ weeks) wild-type (WT-80,
n = 3), SIRT1 overexpressor (OE-80, n = 3), SIRT1 skeletal muscle knockout (MKO-80, n = 3), and SIRT1 satellite cell knockout (SKO-80, n = 3) mice
hindlimbs 21 days after phosphate-buffered saline (PBS) or cardiotoxin (CTX) injection. Basal SKO-80 SIRT1 expression was signiﬁcantly reduced relative
to YWT mice (*P < 0.05), while OE-80 PBS SIRT1 expression was signiﬁcantly increased (***P < 0.001) relative to YWT PBS. Only SKO-80 mice showed a
signiﬁcant increase in SIRT1 abundance for CTX injected muscles relative to their own PBS injected hindlimbs (†P < 0.05). (C) Representative immunoblots of SIRT1 downstream targets FoxO3a and p53 and loading control GAPDH for SIRT1 variant expressers after PBS/CTX injection and recovery.
Densitometric analysis of the immunoblots revealed no signiﬁcant differences in protein expression. (D) Densitometric analysis of the immunoblots
###
#
revealed signiﬁcant differences in the abundance of p53 protein for OE-80 CTX ( P < 0.001) and MKO-80 CTX ( P < 0.05) groups relative to YWT
CTX mice. (E) Representative immunoprecipitation immunoblots for SIRT1 downstream target PGC1α and its acetylation state. (F) Densitometric analysis of relative PGC1α acetylation. No signiﬁcant difference was discovered between groups versus the YWT control when using one-way analysis of
variance with corrections for multiple comparisons.
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Figure 2 The effects of SIRT1 expression on hindlimb skeletal muscle function in young wild-type and older mice. Young wild-type (YWT, 20–30 weeks,
n = 8) and older (80+ weeks) wild-type (WT-80, n = 8), SIRT1 overexpressor (OE-80, n = 9), SIRT1 skeletal muscle knockout (MKO-80, n = 7), and SIRT1
satellite cell knockout (SKO-80, n = 4) mice were anaesthetised with 2–3% isoﬂurane and electrically stimulated once at 75 Hz (A, B) and 180 times at
40 Hz (C-H) to produce muscle contractions (pretreatment, PRE) prior to injection with snake cardiotoxin (CTX) and vehicle control (PBS). Twenty-one
days post-injection, muscle force was re-examined. Data are presented as the mean force at 75 Hz ± SD (***P < 0.01; †P < 0.05) (* denotes a signiﬁcant
difference from the YWT control and † denotes a signiﬁcant difference between a genotype’s control and treatment). (B) Force recovery was measured by
normalizing PBS/CTX data to the same limb pretreatment. Data presented as fold change ± SD. (C) Comparison of all and individual (C–H) fatigue proﬁles
for experimental groups normalized to earliest maximum force. Data are presented as fold change (†P < 0.05, ††P < 0.01, †††P < 0.01,
††††P < 0.001).

production in the muscles of the WT-80 PBS group relative to
the WT-80 PRE group.
We next compared the percent recovery of contractile
force in hindlimb muscles 21 days post-recovery from CTX injection (Figure 2B). The maximal post PBS-injection or CTXinjection plantar ﬂexion force was normalized to the respective pretreatment force output for each animal. The aged

mice were expected to show decreased force recovery in
PBS control hindlimbs relative to the young wild-type mice.
However, despite the WT-80 having a force recovery under
one-fold, no older group showed signiﬁcantly altered, basal
force recovery in control PBS injected hindlimbs relative to
the YWT PBS group. This suggests that aging did not impair
recovery after injury. Contrary to our original expectations,
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Figure 3 The effects of SIRT1 expression on hindlimb skeletal muscle structure in young wild-type and older mice (A–E). Gastrocnemius and soleus
muscles for YWT (A), WT-80 (B), OE-80 (C), MKO-80 (D), and SKO-80 (E) were dissected after physiological evaluation and ﬂash frozen in methyl-butane
chilled by liquid nitrogen. Cross sections were cut at 16 μm, stained for MHC I (green) or MHC IIa/b and dystrophin (red), and then mounted with DAPI
hardset (blue). Total cross-sectional area (CSA) of gastrocnemius cross sections (F), soleus cross sections (G), and type I ﬁbre cross sections (H) were
calculated by ﬁbre tracing with the ImageJ software package on images captured at 4x resolution. Data are presented as mean ± SD compared to YWT
PBS, (n = 3). [F*] denotes that a signiﬁcant difference was observed for the global one-way analysis of variance tests, but not for speciﬁc comparisons.
(I) The gastrocnemius type I percentage was calculated by dividing the summed type I ﬁbre CSA for each section by the total CSA of the respective
gastrocnemius (n = 3). Scale bar = 100 μm.
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only the youngest group of mice (YWT) showed decreased recovery in maximal hindlimb force from muscles that had been
acutely injured by CTX as compared to PBS treated muscles.
Although the overall plantar ﬂexion force output for SKO-80
hindlimb muscles was signiﬁcantly lower than YWT mice,
the SKO-80 mice appeared to recover to pretreatment levels
after 21 days of recovery. The relative force produced 21 days
after CTX-induced injury was not diminished in the older SKO80 animals as compared to young animals although the absolute levels of force was also depressed in the SKO-80 animals
as compared to other groups.
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Muscle fatigue
Muscle fatigability was examined in hindlimb plantar ﬂexor
muscles from young and older mice by inducing a series of
180 electrically evoke contractions at 40 Hz over a period of
3 min. While the mean force output over time shows the
amount of fatigue occurring in a contracting muscle group,
it does not necessarily mimic resistance to fatigue for those
muscles. Therefore, we examined fatigue resistance by
looking at the depletion of muscle contractile force as a function of consecutive electrically evoked contractions by normalizing the force of each 40 Hz contraction to the force of

Figure 4 The effects of SIRT1 expression on cell replication in older murine skeletal muscle after recovery from injury. (A–D) Tibialis anterior (TA) cross
sections were taken for WT-80 (A), OE-80 (B), MKO-80 (C), and SKO-80 (D) mice 21 days after CTX injury at 4x resolution. Sections were stained against
2
BrdU (green, indicated by white arrows) and dystrophin (red). (E) Total CSAs of TA cross sections were calculated and presented as mean CSA (μm ) ± SD
(n = 3). (F) BrdU positive nuclei (A–D) were quantiﬁed and normalized to their respective TA CSA. Data are presented as mean ± SD (n = 3); (*P < 0.05).
Scale bar = 100 μm. CSA, cross-sectional area
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the initial 40 Hz contraction (Figure 2C–2H). The baseline fatigability of the young pretreatment wild-type mice (YWT PRE)
mice did not differ signiﬁcantly from the fatigability of the
WT-80 PRE, OE-80 PRE, MKO-80 PRE, or SKO-80 PRE groups
(Figure 2D and 2H). Neither acute muscle injury from CTX
nor injection with the PBS vector control had signiﬁcant effects on muscle fatigability in YWT, WT-80, or SKO-80 mice
post-recovery (Figure 2D, 2E, and 2H). Surprisingly, muscles
that underwent repair after CTX injury had greater fatigue resistance in both the aged SIRT1 overexpression and skeletal
muscle knockout models of SIRT1 (Figure 2F and 2G). The
OE-80 CTX group showed the greatest magnitude and most
consistent attenuation of fatigue following recovery from
acute muscle injury, and the OE-80 CTX was also the only
group to show signs of post-activation potentiation, so that
muscle contractile force increases with time rather than
diminishing. Although the effect was smaller for the MKO80 CTX group compared to the OE-80 CTX mice, protection
from fatigue was present only in muscles that had recovered
from acute CTX injury (Figure 2E–2G), which would have required activation of satellite cells to induce repair. Interestingly, when compared to the fatigability of YWT CTX mice,
the OE-80 CTX and MKO-80 CTX groups still showed signiﬁcant protective fatigue resistance, albeit to a lesser degree,
and were the only groups to do so. Furthermore, the fatigue
resistance seen in the OE-80 CTX and MKO-80 CTX models coincides with the increased abundance of p53 after repair from
CTX as seen in Figure 1C.

Fibre cross-sectional area
Given the greater susceptibility of type II ﬁbres to aging-induced atrophy49 and the general resistance of type I ﬁbres
to sarcopenic changes,50 we decided to investigate the effect
of SIRT1 expression on these two primary muscle ﬁbre types
in the gastrocnemius muscle of older mice. Although the exact ﬁbre type distribution of the mouse gastrocnemius can
vary between strains, the gastrocnemius muscle typically contains a mixture of types I and II muscle ﬁbres although it is
predominantly composed of type II ﬁbres.51 To determine
the effects of SIRT1 expression on gastrocnemius muscle
structure after acute injury, we used immunoﬂuorescence
techniques to determine the CSA of whole muscles, and types
I and II ﬁbres from PBS-injected and CTX-injected gastrocnemius muscles of the YWT and older groups (Figure 3F–3H).
As expected, the CSA for the gastrocnemius muscle was
lower in older mice 21 days after PBS-injection or CTX-injection CSA relative to muscles in YWT mice 21 days after PBS
(Figure 3F). However, we did not ﬁnd a signiﬁcant difference
between any older group and the YWT control. Given that the
Cohen’s d test shows effect sizes greater than 2 standard deviations for two groups (WT-80 PBS and WT-80 CTX), it is
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likely that the absence of signiﬁcance may have been due
to a low sample size.
Similarly, the CSA in the soleus muscle (Figure 3G) had a
signiﬁcant F statistical main effect from one-way ANOVA with
corrections for multiple comparisons; however, no signiﬁcant
differences were found between the YWT PBS control group
and other groups. Groups of mice showing a large effect size
(>1 standard deviation) were YWT CTX, WT-80 PBS, OE-80
CTX, and SKO-80 CTX groups. Next, we calculated mean type
I ﬁbre CSA from each gastrocnemius section (Figure 3A–3E),
from which we calculated the percent type I CSA standardized to the total CSA of the gastrocnemius muscle (Figure 3H).
Despite the apparent difference of the percent of type I ﬁbres, this did not reach a statistically signiﬁcant difference
when represented as a percentage of the entire gastrocnemius muscle CSA or the speciﬁc comparisons of the treatment groups to the YWT PBS control.

Regenerative capacity
Loss of function in aging skeletal muscle is characterized by
reduced capacity for muscle satellite cells to regenerate damaged tissue.52 Previously, our lab has used 5-bromo-20 deoxyuridine (BrdU) administered in water supplied ad
libitum to gauge satellite cell proliferation to an experimental
intervention.24 Therefore, to examine satellite cell division in
response to skeletal muscle regeneration, we injected the TA
muscles of older WT, OE, MKO, and SKO mice with CTX or PBS
as a control and supplied the recovering mice with 0.8 mg/mL
of BrdU for 21 days post-injury. After recovery, the mice were
sacriﬁced, and BrdU expression was identiﬁed in the TA or
gastrocnemius muscles by immunohistochemically. The number of BrdU+ nuclei in CTX-recovery hindlimb muscles were
then counted (Figure 4A–4D) and normalized to the CSA of
their respective muscles. In contrast to the plantar ﬂexor
muscle group, the TAs showed no signiﬁcant difference between PBS and CTX-recovery groups for mean muscle CSA
or effect size (Figure 4E). No signiﬁcant difference was seen
between the MKO-80 and WT-80 groups, while a signiﬁcantly
lower number of BrdU+ nuclei/μm2 was found for the OE-80
and the SKO-80 CTX-recovery groups (Figure 4F). Nevertheless, all animal groups showed effect sizes larger than 1 standard deviation (P ≤ 0.05).
Next, to determine the regenerative capacity of satellite
cells from the older SIRT1 expression variable mouse models,
we isolated satellite cells by FACS and used them in proliferation analysis. Isolated satellite cells were diluted so that
10000 cells could be plated in triplicate onto a gelatin-coated
coverslip in a 24 well plate. Cells were allowed to recover
overnight before treatment with 5-ethynyl-20 -deoxyuridine
(EdU) prior to ﬁxation and permeabilization. Similar to BrdU,
EdU is incorporated into DNA from proliferating cells. Thereafter, images from nine ﬁelds from each coverslip were
Journal of Cachexia, Sarcopenia and Muscle 2019; 10: 929–949
DOI: 10.1002/jcsm.12437

941

The role of Sirt1 in muscle

captured and the total number of EdU+ cells were counted
(Figure 5A–5D). The proliferation factor was calculated and
expressed as the number of EdU+ cells in nine image ﬁelds
over the number of cells initially plated. Satellite cells that
were isolated from muscles of MKO-80 mice showed a significant increase in proliferation relative to WT-80 mice, with an
effect size greater than 3 standard deviations (Figure 5E).

Mitochondrial structure and function
There is likely a link between mitochondrial dysfunction and
aging53 including sarcopenia.4 As SIRT1 is a known regulator
of PGC1α which in turn regulates mitochondria biogenesis,
we next decided to investigate the effects that SIRT1 expression levels had on mitochondrial activity in the skeletal

Figure 5 The effects of SIRT1 expression on satellite cell proliferation in older murine skeletal muscle. (A–D) EdU+ cells were identiﬁed from FACS-isolated satellite cell populations from TA muscles of WT-80 (A), OE-80 (B), MKO-80 (C), and SKO-80 (D) mice. (E) The proliferation factor was determined
by the total of EdU+ cells counted from nine ﬁelds, normalized to the total number of cells in the plate. Experiments were repeated in triplicate, and
data are presented as mean ± SD (n = 3); (*P < 0.05).
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Figure 6 Characteristics of mitochondria in young wild-type and older SIRT1-expression models of murine skeletal muscle. Plantar ﬂexor muscle groups
(gastrocnemius, soleus, and plantaris) were obtained from YWT and older SIRT1-expressor mice prior to isolation of interﬁbrillar mitochondria (IFM)
and subsarcolemmal mitochondria (SSM) subpopulations. Signiﬁcant differences were found in the sizes of older mitochondria relative to YWT mitochondria for both SSM (A) and IFM (D). No signiﬁcant differences were found for speciﬁc comparisons of internal complexity in SSM (B) or in IFM (E).
OE-80 showed a signiﬁcantly lower mitochondrial membrane potential (ΔΨm) than YWT mice mitochondria as reﬂected in the lower ratio of orange/
green mitochondria relative to YWT in SSM (C) and IFM (D) [F*]. MKO-80 mice and OE-80 mice show the potential for having inversely affected ΔΨm
(F). The shift from green to orange occurs as the JC-1 dye forms aggregates upon membrane polarization causing shifts in emitted light from 530
(green) to 590 nm (orange). Addition of 200 μM dinitrophenol, which collapses the ΔΨm was used as an assay control. Data are expressed as the mean
orange ﬂuorescence divided by the mean green ﬂuorescence of 20000 mitochondrial events per individual mitochondrial sample. The activity for mitochondrial electron transport chain complexes was calculated for SSM (G–J) and IFM (K–N). OWT-80 showed increased complex III activity in SSM (H),
while OE-80 mice showed decreased ATP synthase activity (J). Complex IV activity is depressed in older WT and OE models in SSM, but not SIRT1 knockout models (I). Data are presented as mean ± SD (n = 5). (*P < 0.05, **P < 0.01, ***P < 0.001). [F*] denotes that a signiﬁcant difference was observed
for the global one-way analysis of variance tests, but not for speciﬁc comparisons.
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muscle of older mice. To determine changes in mitochondrial
size and complexity/granularity, freshly isolated IFM and SSM
subpopulations were analysed in control mice by forwardscattering and side-scattering light, respectively.44,54 Mitochondria were isolated from the same mice that were used
for satellite cell isolation experiments, and therefore, it was
not possible to evaluate mitochondria after CTX experiments
in these mice. Older mice had greater mitochondrial size for
both SSM and IFM relative to YWT control mice for both
SIRT-1 overexpressor and knockout groups (Figure 6A and
6D). No signiﬁcant difference was found for the internal complexities of IFM or SSM; however, a signiﬁcant F ratio was
found for the SSM internal complexity, despite having no signiﬁcant differences among the groups relative to the YWT
control (Figure 6B and 6E).
Changes in mitochondrial membrane potential (ΔΨm) typically occur in tangent with diseases like diabetes45,54 and also
in aging.55 Isolated mitochondria were incubated with
5,50 ,6,60 -etrachloro-1,10 ,3,30 -tetraethylbenzimidazol
carbocyanine iodide (JC-1). A shift from JC-1 green to red
ﬂuorescence indicated an increase in the ΔΨm. Previous
studies have shown mitochondria from diabetic animals or
humans had a greater orange/green ratio as compared to
control mitochondria.45,54 A signiﬁcantly lower ΔΨm was
found in SSM populations for OE-80 mice relative to YWT
control mice as reﬂected by a lower orange/green ﬂuorescent
ratio (Figure 6C). A similar decrease in ΔΨm was seen for the
IFM mitochondria in OE-80 mice, although statistical signiﬁcance was not achieved (Figure 6F). While signiﬁcant differences for ΔΨm were not found between groups, a one-way
ANOVA with corrections for multiple variances with the
Dunnett’s test (P = 0.05), the global analyses revealed a statistical difference between the group means. Given the large
effect sizes for some of the groups (>1 SD), it is possible that
the marginally non-signiﬁcant pairwise contrasts in (Figure 6F)
may have produced a signiﬁcant difference if there the experimental sample size had been larger.

differences between the means. No signiﬁcant group differences were found for IFM complex I activity (Figure 6K),
complex III activity (Figure 6L), or complex IV activity
(Figure 6M); however, the global analysis did show that a
signiﬁcant difference existed for the IFM ATP synthase
activity (Figure 6N).

Discussion
In skeletal muscle, SIRT1 has been established as a regulator
of PGC1α and consequently, mitochondria,21,56 which are important for generating ATP during muscle repair. SIRT1 is generally high in type I ﬁbres and promoted by endurance
exercise.48 Because type I oxidative ﬁbres are generally
though to resist aging-related atrophy, SIRT1 has become a
target of interest in studies of sarcopenia with a potential role
in preventing muscle wasting. Support for this idea came
from studies that show overexpression of SIRT1 prevented
type I ﬁbre atrophy under conditions of long-term caloric deficit.15 Furthermore, SIRT1 overexpression also improved the
pathophysiology of muscle wasting including Duchenne muscular dystrophy.50 The data in the present study show that
SIRT1 is important for proper muscle function in older mice,
with loss of function most impactful to muscle satellite cells.
This suggests that SIRT1 may have a role in satellite cell regulated muscle repair. Unexpectedly, both our SIRT1 overexpressing model (OE-80) and skeletal muscle-speciﬁc SIRT1
knockout model (MKO-80) demonstrated increased resistance to muscle fatigue after recovering from acute CTXinduced muscle damage. Although knocking out SIRT1 in satellite cells impairs muscle contraction in aged mice, ablation
of SIRT1 from skeletal muscle promotes satellite cell proliferation and therefore the muscle’s regenerative capacity, suggesting that the most beneﬁcial or detrimental effects of
SIRT1 may be determined by its site of localization within
muscle cells.

Mitochondrial complex activity and muscle repair
To further examine the effects of variant SIRT1 expression
coupled with aging on mitochondria, we next assessed the
relative activity of the mitochondrial electron transport
chain complexes in control muscles. These same mice were
used for satellite cell isolation experiments, and therefore, it
was not possible to evaluate mitochondria following CTX injury in these mice. Signiﬁcant differences were found for activities of the SSM complexes, speciﬁcally a greater complex
III activity for WT-80 mice (Figure 6H) and a reduced ATP
synthase activity for OE-80 mice (Figure 6J). No signiﬁcant
change was seen for SSM complex I activity (Figure 6G) or
SSM complex IV activity (Figure 6I), although the one-way
ANOVA global test did suggest there was a signiﬁcance in

Muscle and satellite cell loss of SIRT1
Interestingly, the MKO and SKO models showed differential
effects for SIRT1 knockout. The MKO mice had a greater resistance to fatigue after repair following CTX injury but a similar
level of regenerative capacity as compared to the older
models. In contrast to the SKO model, the cre protein in
the MKO model is induced by the MCK promoter, so SIRT1
is only expressed in mature skeletal muscle. In contrast, the
SKO model’s cre protein is promoted by PAX7 so that SIRT1
is inactive in only satellite cells, but not in skeletal muscle
when PAX7 is downregulated.
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Satellite cell but not muscle loss of SIRT1 reduces
maximal force production

SIRT1 loss in muscle increases acute, but not
long-term proliferation of satellite cell

Muscles from older MKO mice did not have a loss of muscle
force production when compared to age-matched or 20week-old and wild-type control mice. This suggests that loss
or gain of SIRT1 does not affect the muscle’s ability to generate maximal muscle force (presumably by not affecting the
number or general function of the myosin cross bridges). In
contrast, SKO mice that have a satellite cell speciﬁc loss of
SIRT1 had lower overall plantarﬂexion force than young or
older wild type or SIRT1 overexpressor mice, although gastrocnemius and soleus muscles were not markedly smaller
in this group. This suggests that loss of SIRT1 in satellite cells
did not change overall cross bridge number in the muscle’s
CSA, but interestingly, it did affect muscle function. While it
is possible that SIRT1 could affect force per cross bridge, we
think a more likely possibility is that the lower force output
in muscles from SKO mice may indicate a neural problem
which resulted in an incomplete activation of muscle in the
old mice. This could potentially occur at the level of the neuromuscular junction perhaps as an accelerated aging loss of
dystrophin.57 However, this study was not designed to evaluate the role of SIRT1 in neural regulation of force.

Ryall and colleagues reported that knocking SIRT1 out of satellite cells caused premature differentiation of satellite
cells,29 and therefore, we expected SIRT1 loss or overexpression would induce different satellite cell proliferation responses after CTX injury.
In vitro analysis of cell proliferation within 24 h of culturing
isolated satellite cells showed that a muscle knockout of
SIRT1 had the greatest potential for satellite cell proliferation
among the experimental groups. Of the ﬁve experimental
groups, only the MKO model lacked expression of SIRT1 in
skeletal muscle (despite PAX7 not being expressed in skeletal
muscle, western blots showed reduced or ablated bands for
SKO mice, which should only lack SIRT1 in satellite cells).
However, because the SKO muscles showed a comparatively
blunted level of proliferation compared to the MKO model,
muscle loss of SIRT1 while maintaining satellite cell SIRT1 appeared to increase satellite cell proliferation. However, this
potential was not realized in vivo in response to repair following CTX injury.
In vivo proliferation was assessed 21 days after acute CTX
injury in muscles of older mice and was reﬂected by the frequency of BrdU+ nuclei present in muscle sections postrepair. As 21 days represents a point where recovery from
acute injury should be complete, this experiment reﬂected
long-term satellite cell proliferation following an acute injury
and not the rate of cell proliferation. After 21 days, the MKO
model no longer had the greatest proliferation capacity but
instead was the only SIRT1-expressor variant that did not differ signiﬁcantly in the number of BrdU+ nuclei quantiﬁed in
the older, WT-80 group. Both OE-80 and SKO-80 showed signiﬁcantly fewer BrdU+ cells relative to the WT-80 and MKO80 models. This indicates that factors outside of the satellite
cells (potentially crosstalk between muscle and satellite cells)
in vivo limited satellite cell proliferation in muscles of old animals, and one of those could be muscle SIRT1.

SIRT1 expression may improve but is not necessary
for recovery of muscle function after injury
Muscle repair is dependent upon satellite cell activation and
satellite cell function thought to be depressed with aging.23,52 In elderly humans, SIRT1 activation by resveratrol
was shown to be associated with increased satellite cell activation in response to loading exercise.27 Although the
MKO-80 and OE-80 aged models in our study vary with respect to their levels of SIRT1 expression in skeletal muscle,
both groups showed some improvement in fatigue resistance in response to repeated contractions of muscles in
hindlimbs previously injured by CTX as compared to uninjured control muscles. This fatigue resistance was not
reproduced in CTX-injured hindlimbs for the YWT, WT-80,
or SKO-80 models after a 21-day recovery period that was
observed in the other groups. Furthermore, none of the ﬁve
animal groups experienced a loss of function during the
fatigue testing in hindlimbs injured by CTX or injected with
the PBS control, indicating that functional recovery of
skeletal muscle is not inﬂuenced by loss or gain of SIRT1
abundance in skeletal muscle. The gain of function after injury in both SIRT1 overexpressor and SIRT1 knockout
models suggests a common repair-induced modiﬁcation in
muscle function may exist as long as some SIRT1 is present
in satellite cells (even if it does not exist in the muscle cells
per se).

Mitochondrial function and SIRT1 in muscle
As SIRT1 has a role in regulating oxidative metabolism and
connecting global metabolism to longevity and regeneration,
we also examined mitochondrial subpopulations to identify
potential differences in these subpopulations resulting from
variant SIRT1 expression. Mitochondrial dysfunction may be
a fundamental component that regulates aging responses
along several pathways.27,58 Previous work has suggested
that IFM and SSM subpopulations are affected differently
in cardiac muscle by diabetes.54 Furthermore, SIRT1 is a
regulator of PGC1α which moderates mitochondrial
proliferation.59
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As a reduced mitochondrial membrane potential has been
characterized as an effect of aging and correlates with increased reactive oxygen species (ROS) production,55,60 we
had expected that mitochondrial membrane potential
(ΔΨm) would be improved when SIRT1 was overexpressed
in muscles of older mice, but this was not the case. Interestingly, we saw that muscles from older mice overexpressing
SIRT1 had a signiﬁcantly lower ΔΨm and ATP synthase activity
in the SSM subpopulation. While we found a signiﬁcant F ratio
for IFM ΔΨm by one-way ANOVA, there was no signiﬁcance
difference in mitochondrial function between animal groups
(denoted in our ﬁgures by F*), for IFM-ΔΨm and IFM ATP
synthase activity. The IFM results may have been a function
of signiﬁcant differences in activity that were masked by the
low sample sizes of the experiments. While it is possible that
the decrease in ΔΨm in muscle mitochondria from SIRT1
overexpressor mice may extend to the IFM subpopulation
as well, we cannot verify this in the current study.
Despite loss of SIRT1 function, there was no signiﬁcant differences in muscle mitochondrial characteristics among MKO80, SKO-80, and YWT mice aside from signiﬁcantly increased
size in the older mice (perhaps as a function of decreased mitochondrial ﬁssion or increased fusion). Because analysis of
these mitochondria was performed on isolated skeletal muscle and not isolated satellite cells, some differences in mitochondrial characteristics may be present during the repair
process in satellite cells that could contribute to a reduced
maximal contraction force in muscles of SKO-80 mice, or
the increase in proliferation of satellite cells seen in MKO-80
mice. However, the similarities between the experimental
models for the majority of the mitochondrial factors closely
reﬂects the physiological data that showed little change between muscle fatigability between pretreatment and salineinjected control groups. The reduced ΔΨm and ATP synthase
activity in SSM from OE-80 mice, coupled with the signiﬁcantly reduced number of proliferating BrdU+ cells detected
after injury, support the idea that mitochondria dysfunction
may impair the recovery of muscle injury in aging.61 The force
and fatigue data collected before and after injury suggest
that alterations in mitochondria characteristics did not impair
muscle function after repair from CTX-induced injury.
One explanation for the increased satellite cell proliferation seen in MKO-80 mice after injury and the blunted satellite cell response seen in the OE-80 model might be related to
the mitochondrial related ROS concentration in the relative
cellular environments. For example, attenuation of muscle regeneration in satellite cells from old mice was shown to decrease when aged satellite cells were paired to young
circulatory environments,23 indicating that repair can be inﬂuenced by the local cellular environment. Several studies
have suggested that excess ROS generated from mitochondrial respiration can damage cellular structures and may contribute to cellular aging.62 It is possible, although speculative,
that skeletal muscle containing high levels of SIRT1 may
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release more mitochondrial-associated ROS than SIRT1
knockout models during injury and repair and thereby impair
the proliferation capacity in satellite cells during muscle repair. Although our study was not designed to measure ROS
levels, we did see a reduction in SSM-ΔΨm and in ATP synthase activity for the OE-80 model. Reduced NAD+ and SIRT1
activity has been observed in aged tissues, concurrent with
reduced mitochondrial respiratory chain activity and decreased expression of proteins that protect against oxidative
damage.63 Conversely, treatment with nicotinamide, the precursor to the SIRT1 cofactor nicotinamide adenine dinucleotide (NAD+), has been shown to increase mitochondrial
membrane potential and decrease ROS concentration
through pathways utilizing,64 and pathways independent of
SIRT1.65 It is possible that the OE-80 model, which has increased expression of SIRT1 and a decreased SSM-ΔΨm, is
depleting NAD+ more than wild-type or knockout models. If
this was the case, nicotinamide abundance would be decreased and ROS abundance would be increased, which in
turn would be expected to reduce satellite cell proliferation
as a result of greater oxidative damage.
As resveratrol-mediated SIRT1 activation was shown to be
protective against ROS-induced mitochondrial-mediated apoptotic signalling in muscle,41 and SIRT1 increases antioxidant
production in muscle,27,32 we had expected that mitochondrial function would be improved in muscles that
overexpressed SIRT1 after repair following CTX injury mice.
However, muscles from OE-80 animals had the lowest SSMΔΨm and SSM ATP synthase activity. As SSM lie close to satellite cells, we would have expected this mitochondrial subpopulation to have the greatest impact on proliferating
satellite cells if mitochondria were important for this process.
Nevertheless, the abundance of BrdU positive satellite cell
nuclei were not different in muscles among OE-80, MKO-80,
or SKO animals after repair from CTX-injury. Thus, the potential for SIRT1 abundance to alter mitochondria did not appear
to affect the potential for satellite cell-proliferation during repair after CTX injury.

p53 protein abundance is increased in SIRT1
variant models that gained improved muscle
function after recovery from cardiotoxin-induced
injury
Tumour suppressor p53 is a well-characterized downstream
target of SIRT1. While SIRT1 deacetylation usually inhibits
p53 activity, p53 can be upregulated through several pathways, especially in response to cellular stress or damage.66 Indeed, p53 was only found to be signiﬁcantly increased in the
CTX-injured muscle of the OE-80 and MKO-80 models, but
only when compared to basal levels of p53 in control muscles
that have also recovered from CTX injury. Because one of the
main functions of p53 is to repair DNA in response to injury,
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the presence of p53 in the CTX-injured muscles provides a
plausible explanation as to why our OE-80 and MKO-80
mouse models that have opposite protein abundances of
SIRT1 could paradoxically both beneﬁt from CTX-induced injury. Furthermore, p53 has recently begun to emerge as an
important factor in exercise metabolism, as genetic knockouts of p53 reduce IFM and SSM mitochondrial yield, inhibit
mitochondrial respiration, and reduce exercise capacity during fatiguing exercises in rodent models.67 Interestingly, although the expression of p53 coincides with improved
fatigue resistance in the SIRT1 muscle knockout, the improvement in muscle function after CTX-recovery is markedly
greater in the OE-80 model, indicating high synergy between
the abundances of the SIRT1 and the p53 proteins during
muscle recovery.

Expression of p53 may underlie the attenuation of
MKO-induced satellite cell proliferation
Previous work has established that SIRT1 expression in satellite cells helps to maintain the quiescence of satellite cells
and that eliminating SIRT1 in satellite cells causes premature
proliferation.29 Normal downregulation of SIRT1 in satellite
cells precedes a metabolic shift from fatty acid metabolism
to glycolysis, which is a necessary step for the transition between quiescence and proliferation. Because the metabolic
proﬁle of stem cells also acts to regulate proliferation and
differentiation,68 it is possible that the increased satellite cell
proliferation seen in the MKO mouse model is due to the
absence of SIRT1 in muscle that disrupts the necessary metabolic change required to end satellite cell proliferation. This
possibility is strengthened by evidence showing that there is
an increased abundance of p53 in the CTX-injected hindlimb
muscles of the MKO mouse model and that there is an attenuation of satellite proliferation that was identiﬁed by
BrdU+ 21-day post-CTX injury. This is because overloadinduced muscle growth increases nuclear p5369 and ablating
p53 activity reduces myoblast differentiation.70 A likely scenario is that in the absence of SIRT1 in MKO muscle causes
satellite cells to undergo increased proliferation (a reduced
proliferation ‘off-signal’), while the overexpression of SIRT1
would inhibit proliferation, which corresponds to a lower
number of BrdU+ cells in the OE-80 model when compared
to WT-80. Ironically, CTX-induced muscle damage that
should promote satellite cell proliferation to stimulate repair
also increased p53 expression, which would be expected to
inhibit proliferation and promote differentiation in satellite
cells of the repairing muscles in MKO-80 mice and potentially lead to muscle growth/repair. This is consistent with
the observation that cell proliferation was attenuated in isolated satellite cells from MKO-80 mice in vitro after 24 h by
EdU analysis.
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The synergistic effects of SIRT1 and p53 that
improve fatigue resistance after injury may also
protect type I ﬁbres from sarcopenic wasting
Although the expression of p53 in the CTX-recovery hindlimbs
of the MKO-80 mice provides a possible explanation as to
why the MKO-80 mice have attenuated satellite cell proliferation after CTX injury and why injury may induce a protective
effect against fatigue, the inhibitory effect that SIRT1 exerts
on p53 suggests that co-expression in muscle ﬁbres should
ablate the protective effects of p53 on fatigability. To the
contrary, our data show that the OE-80 mice gain a strong
protective effect against fatigue when p53 is upregulated in
hindlimbs following CTX injury and even show signs of improving muscle function following injury through postactivation potentiation.71,72 One possible explanation is that
the inhibition of p53 by SIRT1 only inhibits p53 activity detrimental to oxidative ﬁbres, but not mitochondrial function or
DNA repair activity crucial to preventing metabolic ROS damage. Furthermore, p53 is an established upregulator of
immobilization-induced skeletal muscle atrophy.73 Selective
inhibition of this activity could explain why type I muscle ﬁbres are resistant to sarcopenic wasting while type II ﬁbres
selectively undergo atrophy. It will be interesting to determine in future studies if co-expression of SIRT1 and p53 selectively inhibit atrophy-related activity but not the DNA repair
functions, thereby ensuring that p53 cannot promote atrophy
in oxidative ﬁbres, where SIRT1 is highly expressed.

Study limitations
The loss of older mice which died at old ages prior to
conducting these studies and removal of mice due to deteriorating health conditions at old ages limited the number of
animals that were available to complete the experiments
and therefore reduced the power of the study. The low number of older animals available for this study prevent us from
obtaining mitochondrial measures in muscles after repair
from CTX. The lower than ideal number of animals may also
have contributed to several experiments which had signiﬁcant differences in their global one-way ANOVA analyses
but failed to detect signiﬁcant between group differences.
Due to the large effect sizes for some of the values calculated
by the respective Cohen’s d statistics, the likelihood that
some differences were masked by the sample size numbers
is high. Increasing the power of these experiments and
expanding the scope of the mitochondrial aspects of the
study to include ROS production and mitochondrial respiration could potentially elucidate a secondary external role of
SIRT1 in modifying satellite cell viability through oxidative
damage and/or mitochondrial dysfunction.
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Conclusions
The expression of SIRT1 in satellite cells is important for the
functional development of skeletal muscle both initially and
for full muscle regeneration. However, despite its functional
signiﬁcance in immature skeletal muscle, SIRT1 shows modest
beneﬁt on muscle mass or muscle function when it is
expressed in the older skeletal muscle of C57BL6/jbackground mice after acute injury. Our data suggest that
there is little beneﬁt for the physiological force or fatigue responses by overexpression of SIRT1 in vivo in the repaired
older skeletal muscle of mice in the absence of any other interventions. However, SIRT1 may synergistically improve the
effect of beneﬁcial proteins like p53 after injury, improving
muscle adaptability and functionality. Ablation of basal SIRT1
expression in satellite cells, however, critically impacts
future/mature muscle function, resulting in lower force production. The MCK-driven knockout of SIRT1 in the skeletal
muscle of older mice showed an improved satellite cell dependent muscle regeneration potential, but this regeneration
is possibly attenuated by the expression of p53 after muscle
injury. Future work is needed to identify the synergistic effects between SIRT1 and p53 in muscle repair. We speculate
that the beneﬁcial effects produced by co-expression of SIRT1
and p53 may also underlie important mechanisms related to
longevity, potentially including the mechanism behind type I
ﬁbre preservation during sarcopenia.
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